Stocks to buy: Fortis, Dr. Reddy among top picks, here’s why

Indian stock market: The Nifty index is showing signs of near-term bearishness as it forms a…

Q4 results: From L&T, Tata Motors to SBI – these companies to declare earnings

In the domestic market, stock-specific movements will be influenced by the upcoming Q4 earnings reports. Dr.…

Cipla, Aurobindo, Torrent are 3 picks of HSBC on healthy Q4 expectations

The strong growth in the US markets led by large product launches has helped drive earnings…

Dr. Reddy’s to promote and distribute Sanofi’s vaccine brands

New Delhi: Dr. Reddy’s Laboratories Limited (DRL), the Hyderabad-based pharmaceutical major, has announced an exclusive partnership…

Pharma Outlook 2024: How are Cipla, Sun Pharma, others likely to perform?

All these factors have recently contributed to the strong earnings of domestic pharma companies.  As we…

Aurobindo Pharma, other pharma stocks rise up to 94% this year. Here’s why

Stocks such as Glenmark Pharma have surged 94 per cent this year so far while Aurobindo…

55 stocks to trade ex-dividend from July 10-14; LTIMindtree, Titan, M&M in list

Typically, dividends are a form of incentive that is distributed by a listed company from their…

L&T, Dr Reddy’s Lab Q4 Results: What should investors know before trading?

The prices of both the shares declined on Wednesday. L&T shares closed marginally lower on BSE.…

Eight Nifty 50 stocks gain over 10% so far in 2023; check details

nifty 50 It hit its 2023 high on Thursday, May 4, rising 165.95 points to 18,255.80.…

Eris buys nine dermatology brands from Dr Reddy’s for ₹275 crore

Indian drugmaker Eris Lifesciences Ltd on Thursday said it has acquired nine dermatology brands from Dr…